Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cyduct Diagnostics Inc (OP: CYDX )

0.5320 UNCHANGED
Streaming Delayed Price Updated: 9:51 AM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.5320
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.5320
Today's Range 0.5320 - 0.5320
52wk Range 0.1270 - 0.5320
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CYduct Diagnostics Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer
Via ACCESSWIRE
CYduct Diagnostics Proudly Supports the "Find It Early Act" to Advance Women's Health
Via ACCESSWIRE

Performance

YTD
+18.22%
+18.22%
1 Month
N/A
N/A
3 Month
+303.64%
+303.64%
6 Month
+77.33%
+77.33%
1 Year
+4.31%
+4.31%

More News

Read More
CYduct Diagnostics Inc. Advocates for Breast Cancer Awareness Month: Pioneering Innovation and Early Detection
Via ACCESSWIRE
Cyduct Diagnostics Recognizes a Visionary Leader in Breast Health: Dr. Susan Love
Via ACCESSWIRE
CYduct Diagnostics Sponsors the Dr. Susan Love Foundation for Breast Cancer Research's 15th Annual Walk With Love
Via ACCESSWIRE
Cyduct Diagnostics Inc. Proudly Sponsors Camp Breastie 2023
Via ACCESSWIRE
CYduct Diagnostics Recognized as April's "Innovator of the Month" by U.S. Senator Chris Murphy
Via ACCESSWIRE
CYduct Diagnostics Inc. Clinical Team Wins Grant and Takes the Stage at the Dr. Susan Love Foundation’s 11th International Symposium on the Human Breast
Via ACCESSWIRE
CYduct Diagnostics Inc. Provides a Corporate Outlook for 2023
Via ACCESSWIRE
CYduct Diagnostics Inc. Completes Audit of its Consolidated Financial Statements
Via ACCESSWIRE
CYduct Diagnostics, Inc. Issues Annual Shareholder Update and Letter from the President
Via ACCESSWIRE
CYduct Diagnostics, Inc. Joins Connecticut's Biosciences Community
From CYduct Diagnostics, Inc.
Via AccessWire
CYduct Diagnostics, Inc. Announces the Appointment of Anthony L.G., PLLC as Corporate and Securities Counsel
From CYduct Diagnostics, Inc.
Via AccessWire
CYduct Diagnostics, Inc. Announces Year-End Financial Results for Fiscal 2021
From CYduct Diagnostics, Inc.
Via AccessWire
Exposures COVID-19
Cyduct Diagnostics Inc. Retains TPS Thayer, a PCAOB Registered Certified Public Accounting Firm
From CYduct Diagnostics, Inc.
Via AccessWire
CYduct Diagnostics, Inc. Completes Strategic Acquisition
From CYduct Diagnostics, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.